Presentation to Highlight the Potential of Human Embryonic Stem Cell Therapies
Worcester, MA - Robert Lanza, MD, Vice President of Medical and Scientific Development, Advanced Cell Technology, Inc., (OTCBB:ACTC.OB) will deliver a keynote presentation today, "The Promise of Human Embryonic Stem Cell Therapies,” at Biotechniques Live!, held in conjunction with the 10th annual Drug Discovery Technology & Development World Congress conference. Dr. Lanza will present at 4:30 p.m. EST, August 10, 2005, at the Boston Convention and Exhibition Center, Boston, MA.
In the presentation, Dr. Lanza will discuss the potential of embryonic stem cells to regenerate complex tissues and organs, and to treat a wide range of disorders that result from tissue dysfunction. The presentation will highlight the recent progress that has been made in the emerging field of regenerative medicine.
To view or download Dr. Lanza's presentation go to "http://www.advancedcell.com/conference-presentations/":http://www.advancedcell.com/conference-presentations/
Conference information can be found at "http://www.biotechniqueslive.com/default.asp?page=access ":http://www.biotechniqueslive.com/default.asp?page=access
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc., a Nevada corporation, is a biotechnology company applying stem cell technology in the emerging field of regenerative medicine. The company is currently headquartered in Worcester, Massachusetts. For more information about the company visit http://www.advancedcell.com
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and its subsidiary, Advanced Cell, Inc., and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company's periodic reports, including the report on Form 10-QSB for the quarter ended March 31, 2005.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company's management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Frequently Requested Info